The Oncology Institute, Inc. (TOI) Covered Calls

The Oncology Institute, Inc. (TOI) is a leading provider of value-based oncology services in the United States. The company offers evidence-based cancer care through a community-based delivery model, including clinical trials, infusions, and stem cell transplants. By partnering with health plans and integrated pharmacy services, TOI aims to deliver high-quality, cost-effective cancer treatment while improving the overall patient experience in convenient, local clinic settings.

You can sell covered calls on The Oncology Institute, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TOI (prices last updated Fri 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

The Oncology Institute operates as a specialized oncology organization that bridges the gap between complex academic cancer care and community-based accessibility. Its business model is built around value-based care contracts, where the company assumes risk to provide more efficient, high-quality treatment paths. By offering a comprehensive suite of services—ranging from in-house dispensaries and infusion centers to clinical trial access—the firm reduces the need for expensive hospital visits and hospitalizations for its patients.

A core differentiator for the company is its integrated platform, which combines medical oncology services with pharmacy operations. This synergy allows TOI to manage the total cost of care while ensuring that patients receive timely, evidence-based interventions. The firm focuses on scaling its model across diverse geographies, partnering with health plans and employer groups to deliver a personalized, human-centered approach to oncology, even for patients with rare or complex diagnoses.

Competition

The oncology services market is highly competitive, featuring both large national healthcare systems and specialized oncology practices. The Oncology Institute competes with entities that offer similar infusion and pharmacy-integrated care models. Success in this sector requires maintaining high standards of clinical efficacy, navigating complex reimbursement landscapes, and building deep, trust-based relationships with referring primary care physicians and specialist networks.

Key publicly traded, optionable competitors include Tenet Healthcare, CVS Health (due to its oncology and pharmacy management services), and U.S. Physical Therapy (in the broader outpatient healthcare services context).

Strategic Outlook and Innovation

The company remains focused on achieving sustainable growth by expanding its footprint into new markets and deepening its penetration within existing regions. A primary strategic priority is the successful scaling of its value-based contracts, which incentivize clinical efficiency and long-term cost savings. The firm also emphasizes the integration of AI-enabled administrative tools to streamline clinical workflows and patient intake, thereby improving overall operational performance.

Innovation is centered on the continuous expansion of its clinical trial portfolio, providing patients with access to cutting-edge therapies that may not be available elsewhere. By fostering strategic collaborations and leveraging its proprietary oncology data, the company seeks to maintain its leadership position in the value-based community oncology space. The focus remains on driving long-term value through disciplined operational execution and the continued delivery of transformative care to patients facing cancer.

Want more examples? TNL Covered Calls | TOL Covered Calls